MRI隨訪在經(jīng)導(dǎo)管灌注治療非創(chuàng)傷性股骨頭缺血性壞死療效評(píng)估中的價(jià)值
發(fā)布時(shí)間:2018-04-21 16:14
本文選題:股骨頭 + 壞死; 參考:《臨床放射學(xué)雜志》2016年04期
【摘要】:目的探討MRI隨訪在經(jīng)導(dǎo)管動(dòng)脈灌注(TAI)治療非創(chuàng)傷性股骨頭缺血性壞死(ANFH)療效評(píng)估中的價(jià)值。方法對(duì)22例(30髖)經(jīng)臨床和影像學(xué)檢查確診的非創(chuàng)傷性ANFH患者采用TAI治療,并比較治療前后臨床癥狀、髖關(guān)節(jié)功能及MRI影像改變。隨訪觀察9~36個(gè)月。按ARCO分期,0期1髖;Ⅰ期6髖;Ⅱ期20髖;Ⅲa期3髖。結(jié)果 TAI術(shù)后,0期+Ⅰ期患者髖關(guān)節(jié)功能評(píng)分由術(shù)前平均(82.7±2.48)分增至術(shù)后平均(99.98±3.45)分;Ⅱ期患者髖關(guān)節(jié)功能評(píng)分由術(shù)前平均(76.9±3.23)分增至術(shù)后平均(95.07±3.68)分;Ⅲa期患者髖關(guān)節(jié)功能評(píng)分由術(shù)前平均(69.8±1.22)分增至術(shù)后平均(90.09±3.17)分。差異均有顯著性統(tǒng)計(jì)學(xué)意義(P0.05)。MRI隨訪發(fā)現(xiàn)19髖(63.3%)有不同程度好轉(zhuǎn),股骨頭壞死區(qū)病灶穩(wěn)定,見(jiàn)增生、硬化及囊變縮小,骨髓水腫范圍變小,髖關(guān)節(jié)積液減少;2髖(6.7%)病變基本保持不變;9髖(30%)病變加重,表現(xiàn)為骨髓水腫范圍增大、髖關(guān)節(jié)積液增多,但在繼續(xù)隨訪中病變好轉(zhuǎn)。結(jié)論非創(chuàng)傷性ANFH患者TAI術(shù)后MRI隨訪有一定的價(jià)值,但需結(jié)合患者的臨床及其他影像資料才是科學(xué)的隨訪措施。
[Abstract]:Objective to evaluate the value of MRI follow-up in the treatment of nontraumatic avascular necrosis of femoral head (ANFH) by transcatheter arterial infusion (TAI). Methods 22 patients with nontraumatic ANFH diagnosed by clinical and imaging examinations were treated with TAI. The changes of clinical symptoms, hip function and MRI images before and after treatment were compared. The patients were followed up for 9 ~ 36 months. There were 1 hip in stage 0 according to ARCO stage, 6 hips in stage 鈪,
本文編號(hào):1783161
本文鏈接:http://sikaile.net/huliyixuelunwen/1783161.html
最近更新
教材專(zhuān)著